210 related articles for article (PubMed ID: 36436191)
1. Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes.
Massironi S; Rossi RE; Laffusa A; Eller-Vainicher C; Cavalcoli F; Zilli A; Ciafardini C; Sciola V; Invernizzi P; Peracchi M
J Endocrinol Invest; 2023 May; 46(5):957-965. PubMed ID: 36436191
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study.
Massironi S; Cavalcoli F; Elvevi A; Quatrini M; Invernizzi P
Endocrine; 2022 Mar; 75(3):942-948. PubMed ID: 34716542
[TBL] [Abstract][Full Text] [Related]
3. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
[TBL] [Abstract][Full Text] [Related]
5. Zollinger-Ellison syndrome due to primary gastrinoma of the extrahepatic biliary tree: three case reports and review of literature.
Price TN; Thompson GB; Lewis JT; Lloyd RV; Young WF
Endocr Pract; 2009; 15(7):737-49. PubMed ID: 19491075
[TBL] [Abstract][Full Text] [Related]
6. The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?
Guarnotta V; Martini C; Davì MV; Pizza G; Colao A; Faggiano A;
Endocrine; 2018 Apr; 60(1):15-27. PubMed ID: 29019150
[TBL] [Abstract][Full Text] [Related]
7. Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.
Tonelli F; Giudici F; Nesi G; Batignani G; Brandi ML
World J Gastroenterol; 2013 Dec; 19(45):8312-20. PubMed ID: 24363522
[TBL] [Abstract][Full Text] [Related]
8. Zollinger-Ellison syndrome. Clinical presentation in 261 patients.
Roy PK; Venzon DJ; Shojamanesh H; Abou-Saif A; Peghini P; Doppman JL; Gibril F; Jensen RT
Medicine (Baltimore); 2000 Nov; 79(6):379-411. PubMed ID: 11144036
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999].
Mignon M
Bull Acad Natl Med; 2003; 187(7):1249-58; discussion 1259-60. PubMed ID: 15146602
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
11. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
Medicine (Baltimore); ; . PubMed ID: 17108778
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
